Cargando…

Mechanical Signals Inhibit Growth of a Grafted Tumor In Vivo: Proof of Concept

In the past ten years, many studies have shown that malignant tissue has been “normalized” in vitro using mechanical signals. We apply the principles of physical oncology (or mechanobiology) in vivo to show the effect of a “constraint field” on tumor growth. The human breast cancer cell line, MDA MB...

Descripción completa

Detalles Bibliográficos
Autores principales: Brossel, Rémy, Yahi, Alexandre, David, Stéphane, Moreno Velasquez, Laura, Guinebretière, Jean-Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839666/
https://www.ncbi.nlm.nih.gov/pubmed/27100674
http://dx.doi.org/10.1371/journal.pone.0152885
_version_ 1782428160218890240
author Brossel, Rémy
Yahi, Alexandre
David, Stéphane
Moreno Velasquez, Laura
Guinebretière, Jean-Marc
author_facet Brossel, Rémy
Yahi, Alexandre
David, Stéphane
Moreno Velasquez, Laura
Guinebretière, Jean-Marc
author_sort Brossel, Rémy
collection PubMed
description In the past ten years, many studies have shown that malignant tissue has been “normalized” in vitro using mechanical signals. We apply the principles of physical oncology (or mechanobiology) in vivo to show the effect of a “constraint field” on tumor growth. The human breast cancer cell line, MDA MB 231, admixed with ferric nanoparticles was grafted subcutaneously in Nude mice. The magnetizable particles rapidly surrounded the growing tumor. Two permanent magnets located on either side of the tumor created a gradient of magnetic field. Magnetic energy is transformed into mechanical energy by the particles acting as “bioactuators”, applying a constraint field and, by consequence, biomechanical stress to the tumor. This biomechanical treatment was applied 2 hours/day during 21 days, from Day 18 to Day 39 following tumor implantation. The study lasted 74 days. Palpable tumor was measured two times a week. There was a significant in vivo difference between the median volume of treated tumors and untreated controls in the mice measured up to D 74 (D 59 + population): (529 [346; 966] mm(3) vs 1334 [256; 2106] mm(3); p = 0.015), treated mice having smaller tumors. The difference was not statistically significant in the group of mice measured at least to D 59 (D 59 population). On ex vivo examination, the surface of the tumor mass, measured on histologic sections, was less in the treated group, G1, than in the control groups: G2 (nanoparticles, no magnetic field), G3 (magnetic field, no nanoparticles), G4 (no nanoparticles, no magnetic field) in the D 59 population (Median left surface was significantly lower in G1 (5.6 [3.0; 42.4] mm(2), p = 0.005) than in G2 (20.8 [4.9; 34.3]), G3 (16.5 [13.2; 23.2]) and G4 (14.8 [1.8; 55.5]); Median right surface was significantly lower in G1 (4.7 [1.9; 29.2] mm(2), p = 0.015) than in G2 (25.0 [5.2; 55.0]), G3 (18.0 [14.6; 35.2]) and G4 (12.5 [1.5; 51.8]). There was no statistically significant difference in the day 59+ population. This is the first demonstration of the effect of stress on tumor growth in vivo suggesting that biomechanical intervention may have a high translational potential as a therapy in locally advanced tumors like pancreatic cancer or primary hepatic carcinoma for which no effective therapy is currently available.
format Online
Article
Text
id pubmed-4839666
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48396662016-04-29 Mechanical Signals Inhibit Growth of a Grafted Tumor In Vivo: Proof of Concept Brossel, Rémy Yahi, Alexandre David, Stéphane Moreno Velasquez, Laura Guinebretière, Jean-Marc PLoS One Research Article In the past ten years, many studies have shown that malignant tissue has been “normalized” in vitro using mechanical signals. We apply the principles of physical oncology (or mechanobiology) in vivo to show the effect of a “constraint field” on tumor growth. The human breast cancer cell line, MDA MB 231, admixed with ferric nanoparticles was grafted subcutaneously in Nude mice. The magnetizable particles rapidly surrounded the growing tumor. Two permanent magnets located on either side of the tumor created a gradient of magnetic field. Magnetic energy is transformed into mechanical energy by the particles acting as “bioactuators”, applying a constraint field and, by consequence, biomechanical stress to the tumor. This biomechanical treatment was applied 2 hours/day during 21 days, from Day 18 to Day 39 following tumor implantation. The study lasted 74 days. Palpable tumor was measured two times a week. There was a significant in vivo difference between the median volume of treated tumors and untreated controls in the mice measured up to D 74 (D 59 + population): (529 [346; 966] mm(3) vs 1334 [256; 2106] mm(3); p = 0.015), treated mice having smaller tumors. The difference was not statistically significant in the group of mice measured at least to D 59 (D 59 population). On ex vivo examination, the surface of the tumor mass, measured on histologic sections, was less in the treated group, G1, than in the control groups: G2 (nanoparticles, no magnetic field), G3 (magnetic field, no nanoparticles), G4 (no nanoparticles, no magnetic field) in the D 59 population (Median left surface was significantly lower in G1 (5.6 [3.0; 42.4] mm(2), p = 0.005) than in G2 (20.8 [4.9; 34.3]), G3 (16.5 [13.2; 23.2]) and G4 (14.8 [1.8; 55.5]); Median right surface was significantly lower in G1 (4.7 [1.9; 29.2] mm(2), p = 0.015) than in G2 (25.0 [5.2; 55.0]), G3 (18.0 [14.6; 35.2]) and G4 (12.5 [1.5; 51.8]). There was no statistically significant difference in the day 59+ population. This is the first demonstration of the effect of stress on tumor growth in vivo suggesting that biomechanical intervention may have a high translational potential as a therapy in locally advanced tumors like pancreatic cancer or primary hepatic carcinoma for which no effective therapy is currently available. Public Library of Science 2016-04-21 /pmc/articles/PMC4839666/ /pubmed/27100674 http://dx.doi.org/10.1371/journal.pone.0152885 Text en © 2016 Brossel et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Brossel, Rémy
Yahi, Alexandre
David, Stéphane
Moreno Velasquez, Laura
Guinebretière, Jean-Marc
Mechanical Signals Inhibit Growth of a Grafted Tumor In Vivo: Proof of Concept
title Mechanical Signals Inhibit Growth of a Grafted Tumor In Vivo: Proof of Concept
title_full Mechanical Signals Inhibit Growth of a Grafted Tumor In Vivo: Proof of Concept
title_fullStr Mechanical Signals Inhibit Growth of a Grafted Tumor In Vivo: Proof of Concept
title_full_unstemmed Mechanical Signals Inhibit Growth of a Grafted Tumor In Vivo: Proof of Concept
title_short Mechanical Signals Inhibit Growth of a Grafted Tumor In Vivo: Proof of Concept
title_sort mechanical signals inhibit growth of a grafted tumor in vivo: proof of concept
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839666/
https://www.ncbi.nlm.nih.gov/pubmed/27100674
http://dx.doi.org/10.1371/journal.pone.0152885
work_keys_str_mv AT brosselremy mechanicalsignalsinhibitgrowthofagraftedtumorinvivoproofofconcept
AT yahialexandre mechanicalsignalsinhibitgrowthofagraftedtumorinvivoproofofconcept
AT davidstephane mechanicalsignalsinhibitgrowthofagraftedtumorinvivoproofofconcept
AT morenovelasquezlaura mechanicalsignalsinhibitgrowthofagraftedtumorinvivoproofofconcept
AT guinebretierejeanmarc mechanicalsignalsinhibitgrowthofagraftedtumorinvivoproofofconcept